Formulary Search
A to Z of Drugs : A
Records returned : 196 (on 29 May 2025 at 00:55:56).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Auto-injector
Restrictions / Comments:
Important
Narrative entered here will appear on the Formulary page. Keep wording to a minimum and include key points. For example
Restricted to endocrinology only.
Tablets can be crushed for patients with swallowing difficulties (off-label use)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
SASH: Not for use in Sussex patients
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial required GUM specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Severe disease only. NON-FORMULARY for moderate disease
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
MHRA risk JAK inhibitors
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Inadequately controlled diabetes mellitus
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation and stabilisation by the specialist team before transfer of prescribing to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Off label. Acutely decompensated heart failure. RSCH Cardiology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Important
2% spray. Available to purchase from a pharmacy.
Links :
Indication :
Status :
Formulations :
- Irrigation solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
5% and 10% preservative free (unlicensed) eye drops reserved for specialist use in severe dry eye
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
RSCH: Ilube brand for filamentary keratitis (off-label use)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Effervescent tablets
Restrictions / Comments:
Important
Prescribe generically as 600mg effervescent tablets sugar free.
Do not use in patients with bronchospasm or history of asthma.
Do not use in fluid or sodium restricted patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Granules
- Oral solution
- Powder
- Tablets
Restrictions / Comments:
Important
These are either unlicensed or are not considered cost-effective treatment options - see guidelines for recommended products.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Dispersible tablets
- Suspension
- Tablets
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye ointment
Restrictions / Comments:
Important
Not 1st-line due to cost.
Ganciclovir 0.15% eye gel is much less expensive than aciclovir and should be considered 1st-line.
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Combination with LABA recommended in COPD.
Prescribe by BRAND
Formulary Status :
Links :
27. Aclidinium with formoterol (Duaklir Genuair)
Drug:
Aclidinium with formoterol (Duaklir Genuair)
(LAMA LABA)
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Prescribe by BRAND
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Highly specialist centres only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
For UC & CD. Adults only.
Prescribe by brand.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
NHSE Specialised Commissioned Services only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not recommended in line with NICE CG165
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Important
Preferred
STOCARE REMOVE ADHESIVE REMOVER
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Important
Preferred
LIFT PLUS 360 CITRUS ADHESIVE REMOVER
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Important
Other products are considered 2nd-line if 1st-line options are unsuitable (Adapt No-Sting, Easisipray, Remove Apple / Blackberry / Mint, Salts adhesive remover, Brava adhesive remover XL)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Spray
Restrictions / Comments:
Important
APPEEL ADVANCE NO STING - reserved for paediatric use only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Wipes
Restrictions / Comments:
Important
Wipes are 2nd-line. Reserved for travel or adhesive build-up. Consider a spray.
STOCARE REMOVE ADHESIVE REMOVER wipes
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Wipes
Restrictions / Comments:
Important
Wipes are 2nd-line. Reserved for travel or adhesive build-up. Consider a spray.
LIFTEEZ NON-STING adhesive remover wipes
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Wipes
Restrictions / Comments:
Important
Wipes are 2nd-line. Reserved for travel or adhesive build-up. Consider a spray.
Other products are considered 2nd-line if 1st-line options are unsuitable (Universal removal wipes, Salts adhesive remover wipes)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Auto-injector
Restrictions / Comments:
Important
Epipen,/Jext / Emerade - Prescribe by brand.
Injection technique is device-specific
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Ampoules and pre-filled syringes. 1:1,000 and 1:10,000
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
- Pre-filled syringe
Restrictions / Comments:
Important
1:1,000 (1mg/ml) and
1:10,000 (100mcg/ml) - children
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhalation
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
Severe dry eye
Prescribe by brand. Specialist to initiate and supply first month supply
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Aflibercept 2mg (biosimilar when available) remains a first line treatment option (alongside ranibizumab biosimilar).
Aflibercept 8mg can be used in those patients that have not responded sufficiently to the 2mg treat and extend protocols and that aflibercept 8mg will be used no more frequently than every 8 weeks in line with the licence
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Not assessed for inclusion on the formulary. Contact pharmacy team for advice on making an application.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Aflibercept 2mg (biosimilar when available) remains a first line treatment option (alongside ranibizumab biosimilar).
Aflibercept 8mg can be used in those patients that have not responded sufficiently to the 2mg treat and extend protocols and that aflibercept 8mg will be used no more frequently than every 8 weeks in line with the licence
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Highly specialised centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
ASPH are the only Surrey Heartlands Trust commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
ONCE WEEKLY tablets
ONCE DAILY tablets
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Reserve for patients with swallowing difficulties.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Effervescent tablets
Restrictions / Comments:
Important
Reserve for patients who have tried alendronate and/or risedronate but are unable to swallow tablets (as opposed to patients with swallowing difficulties in whom the oral solution may be appropriate).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
See separate listings for palliative care and use in anaesthesia.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Primary Care prescribing on advice from palliative care specialist team
See separate listings for palliative care and use in anaesthesia.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
- Tablets
Restrictions / Comments:
Important
2nd or 3rd line.
Tamsulosin MR capsules or Doxazosin immediate release tablets are preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Restricted to lipidologists only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England guidance DO NOT ROUTINELY PRESCRIBE
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Allergovit - RSFT Immunology only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sub-lingual drops
Restrictions / Comments:
Important
Oralvac Compact drops - RSFT Immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Pollinex quattro - RSFT Immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sublingual tablets
Restrictions / Comments:
Important
Lais tablets (grass pollen) - RSFT immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Off-label use in combination with azathioprine and mercaptopurine
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Not 1st line.
Generic sumatriptan, naratriptan, rizatripan, zolmitriptan are preferred.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Existing patients would not be expected to change therapy unless appropriate to do so.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Sitagliptin is the preferred DPP4.
Reserve combination products for patients in whom separate components are less appropriate.
Existing patients would not be expected to change therapy unless appropriate to do so.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral suspension
Restrictions / Comments:
Important
osteonecrosis of the jaw, ORN, ONJ
FOR ORAL SURGEONS ONLY: Prevention: along with pentoxifylline 1 week before extraction and continue for 3 months (until good healing had been observed). For treatment to be continued long term until healing is observed.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Treatments for ED on the NHS require an SLS endorsement.
Only in patients who do not respond to PDE-5 inhibitors.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intraurethral
Restrictions / Comments:
Important
Treatments for ED on the NHS require an SLS endorsement.
Patient to be provided with training materials prior to request for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intracavernosal injection
Restrictions / Comments:
Important
Treatments for ED on the NHS require an SLS endorsement.
Initiation and assessment of efficacy prior to transfer to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
- Intracavernosal injection
- Intraurethral
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
As per guidance from St Luke's radiotherapy service for the management of immunotherapy-related adverse events: https://www.royalsurrey.nhs.uk/chemotherapy-policies-and-protocols?smbfolder=550
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Alutard - RSFT Immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Venomil - RSFT Immunology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Important
NICE TA168 & 158 do not recommend for use in treatment or prophylaxis of influenza
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. This drug requires therapeutic monitoring
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhalation
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Important
Ophthalmology specialists only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhalation
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhalation
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Severe acute asthma
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Off-label use. Lowest cost treatment option.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Important
Off-label use
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral suspension
- Sachets (SUGAR FREE powder)
Restrictions / Comments:
Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials. Contra-indicated in Penicillin Allergy.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
1st month supply from specialist team before request for primary care prescribing
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Apixaban / rivaroxaban anticoagulant reversal.
RESTRICTED to Haematologists only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Preferred
Sodium cromoglycate 2% or Antazoline with Xylometazoline (Otrivine-Antistin) are the preferred antihistamine/anti-inflammatory eye drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sunscreen lotion SPF 50+
Restrictions / Comments:
Important
Only approved on the NHS for 2 indications - see PAD
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Sunscreen lotion SPF 50+
Restrictions / Comments:
Important
Only approved on the NHS for 2 indications - see PAD
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Ointment
- Suppositories
Restrictions / Comments:
Important
Scheriproct ointment and suppositories are considerably less expensive than Proctosedyl and Anusol HC in primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Extended VTE prophylaxis after robotic cystectomy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pre-filled syringe
- Subcutaneous infusion
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
0.5% drops for short-term adjunctive treatment of chronic glaucoma. In exceptional circumstances it may be necessary for an additional bottle to be prescribed by the GP e.g. where a patient has been unable to apply accurate doses and has run out prior to finishing the required duration of treatment.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
1% preservative free eye drops. Not for primary care prescribing. Used in the immediate pre and post-operative period.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enema
Restrictions / Comments:
Important
Allergy warning - contains peanut oil
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Heamatology only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Oro-dispersible
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
One monthly or two monthly injecton schedule available
- Monthly injection – Deltoid or gluteal muscle
- Injection every 2 months – Gluteal muscle only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Pastilles
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Oromucosal gel
Restrictions / Comments:
Important
For dry mouth associated with radiotherapy or sicca syndrome (Sjögren's syndrome)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oromucosal spray
Restrictions / Comments:
Important
Symptomatic treatment of dry mouth.
ASPH restrict to oncology
Links :
Indication :
Status :
Formulations :
- Dispersible tablets
- Suppositories
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enteric coated tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
This status applies to the use of aspirin for pain.
Refer to separate formulary entries for caridology indications.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Dispersible tablets
- Suppositories
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Enteric coated tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist Approval.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
- Intravenous injection (IV)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Preferred
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
This entry has not yet been reviewed for inclusion on the joint formulary. However, this information has been published due to the ongoing requirement for prescribers to access the shared care agreement and other resources that were in place prior to the launch of the joint formulary.
Please refer to the list of agreed formulations and former traffic light status available on the PAD page (accessed by clicking the drug name).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
- Injection
Restrictions / Comments:
Important
Under specialist supervision in hospital
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
https://www.toxbase.org/
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Sub-lingual drops
Restrictions / Comments:
Important
Off-label use. 1% Eye drops used sublingually. NOTE - the bottles (5ml / 10ml) are VERY expensive in primary care (>£150 per bottle) and should only be used where the unit dose Minims is not suitable and atropine is the required therapy. Primary Care may prescribe on request from the specialist team.
Links :
Indication :
Status :
Formulations :
- Eye drops (unit dose)
- Sub-lingual drops
Restrictions / Comments:
Important
1% Minims eye drops used sublingually. Each unit dose can continue to be used for 24 hours after opening (multiple doses). One Minims unit per day. Off-label use. Primary Care may prescribe on request from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
Pralidoxime stock not held by Surrey Trusts. Available from regional centres - see TOXBASE / NPIS for details.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
Preferred
Unit dose Minims is the preferred formulation. Initiation by specialist. Transfer to primary care may be suitable after a minimum of 2 months supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Reserve the 1% eye drops in bottles for patients with poor dexterity and are unable to use unit dose Minims drops. The bottles are disproportionately expensive in Primary Care.
Transfer to primary care may be suitable after a minimum of 2 months supply from the specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Haematology use only - treating primary chronic immune thrombocytopenia as per NICE TA853.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Hepatology use only - treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure as per NICE TA626
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intracavernosal injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Suspension
- Tablets
Restrictions / Comments:
Important
For EXISTING patients only - GPs may continue prescribing for existing post-transplant patients only. NHS England are looking to repatriate these patients in the future. GPs must not accept requests to prescribe for new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Suspension
- Tablets
Restrictions / Comments:
Important
For NEW patients - funded by NHS England. GPs should not accept any new request to start prescribing post-transplant
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal spray
Restrictions / Comments:
Important
Recommended as an alternative where an intranasal antihistamine is indicated
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral suspension
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines, NICE condensed summary table of antimicrobial guidance or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by NICE guidelines, local trust antimicrobial guidelines or specialist microbiology recommendation
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Nebuliser solution
Formulary Status :
Links :